ADAS cog

Related by string. ADAS Cog * ada . Adas . ADAs . Ada . Adad . ADAD : Can ada . ADA compliant restrooms . GNAT Ada Java Interfacing . Disabilities Act ADA . C. Ada Gymnasium . La Caà ± ada . ADA accessibility . -Louisa Ada Seltzer / cogs . Cogs . COGS . Coger . COGs . COG . Cog . CoGS : Pikes Peak Cog Railway . vital cog . vital cogs . renovated Cog Hill . SEDA COG . integral cog . key cog . Cog Hill Golf * *

Related by context. Frequent words. (Click for all words.) 73 PANSS 71 MMSE 69 ADHD RS 67 symptom severity 67 virologic response 66 IPSS 64 achieved statistical significance 64 Secondary endpoints included 64 Global Impression 64 Secondary endpoints 63 QoL 63 DAS# [002] 63 ANOVA 63 LVEF 62 subscales 62 Disease Activity 62 Rating Scale 62 placebo p = 62 P = .# 61 placebo p 61 HbA1c levels 61 Mini Mental 61 EDSS 61 creatinine clearance 61 ± SD 61 QTc 60 noninferiority 60 Secondary endpoints include 60 haloperidol 60 plus methotrexate 60 fasting insulin 59 mg QD 59 preoperatively 59 T2DM 59 Main Outcome Measures 59 virologic 59 fasting plasma glucose 59 FEV1 59 tocilizumab 59 prespecified 59 glycated hemoglobin 59 tiotropium 58 secondary endpoint 58 bosentan 58 logistic regression 58 mg kg dose 58 rotigotine 58 annualized relapse 58 p = #.# [002] 58 glatiramer acetate 58 Postoperative 58 glomerular filtration rate 58 pramipexole 57 Prognostic 57 serum phosphorus 57 donepezil 57 HRQOL 57 sustained virologic response 57 mg BID 57 unfractionated heparin 57 virologic failure 57 statistically significant p 57 composite endpoint 57 carotid intima media 57 infarct size 57 clinical endpoints 57 p = #.# [004] 57 lymphopenia 56 nonsignificant 56 adalimumab 56 sensitivity specificity 56 ACR# [002] 56 estimated glomerular filtration 56 covariance 56 demonstrated statistically significant 56 quetiapine 56 CD4 + cell 56 TIMI 56 lacosamide 56 plus prednisone 56 histologic 56 dyspnea 56 laboratory abnormalities 56 ziprasidone 56 etanercept 56 microalbuminuria 56 citalopram 56 MetS 56 clinically meaningful 56 echocardiographic 56 secondary efficacy endpoints 56 nonresponders 55 FOLFIRI 55 aripiprazole 55 lamotrigine 55 active comparator 55 mcg kg 55 D dimer 55 hypomagnesemia 55 PCa 55 postoperatively

Back to home page